Background Image
Table of Contents Table of Contents
Previous Page  44 / 68 Next Page
Information
Show Menu
Previous Page 44 / 68 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 26, No 3, May/June 2015

142

AFRICA

References

1.

Sharma R, Francis DP, Pitt B,

et al

. Haemoglobin predicts survival in

patients with chronic heart failure: a substudy of Elite II trial.

Eur Heart

J

2004;

25

: 1021–1028.

2.

Horwich TB, Fonarow GC, Hamilton MA,

et al

. Anemia is associated

with worse symptoms, greater impairment in functional capacity and a

significant increase in mortality in patients with advanced heart failure.

J Am Coll Cardiol

2002;

39

: 1780–1786.

3.

Kosiborod M, Smith GL, Radford MJ,

et al

. The prognostic importance

of anemia in patients with heart failure.

Am J Med

2003;

114

: 112–119.

4.

Mozaffarian D, Nye R, Levy WC. Anemia predicts mortality in severe

heart failure.

J Am Coll Cardiol

2003;

41

: 1933–1939.

5.

Al-Ahmad A, Rand WM, Manjunath G,

et al

. Reduced kidney function

and anemia as risk factors for mortality in patients with left ventricular

dysfunction.

J Am Coll Cardiol

2001;

38

: 955–962.

6.

Felker GM, Shaw LK, Stough WG,

et al

. Anemia in patients with heart

failure and preserved systolic function.

Am Heart J

2006;

151

: 457–462.

7.

O’Meara E, Clayton T, McEnlegart MB,

et al

. Clinical correlates and

consequences of anemia in a broad spectrum of patients with heart

failure: results of the Candesartan in Heart Failure: Assessment of

Reduction in Mortality and Morbidity (CHARM) Program.

Circulation

2006;

113

: 986–994.

8.

Mitchell JE. Emerging role of anemia in heart failure.

Am J Cardiol

2007;

99

: 15D–20D.

9.

Cleland JGF, Swedberg K, Follath F,

et al

. The EuroHeart Failure

Survey Program. A survey on the quality of care among patients with

heart failure in Europe.

Eur Heart J

2003;

24

: 442–463.

10. Abassade P, Rabenirina F, Garcon P,

et al

. L’anémie dans l’insuffisance

cardiaque.

Ann Cardiol Angéiol

2009;

58

: 289–292.

11. Kuule JK, Seremba E, Freers J. Anemia among patients with congestive

cardiac failure in Uganda – its impact on treatment and outcomes.

S Afr

Med J

2009;

99

: 876–880.

12. Oyoo GO, Ogola EN. Clinical and sociodemographic aspects of conges-

tive heart failure patients at Kenyatta National Hospital, Nairobi.

East

Afr Med J

1999;

76

: 23–37.

13. Damasceno A, Mayosi BM, Sani M,

et al

. The causes, treatment, and

outcome of acute heart failure in 1006 Africans from 9 countries.

Arch

Intern Med

2012;

172

: 1386–1394.

14. Tang YD, Katz SD. Anemia in chronic heart failure: prevalence, etiol-

ogy, clinical correlates, and treatment options.

Circulation

2006;

113

:

2454–2461.

15. Drakos SG, Anastasiou-Nana MI, Malliaras KG,

et al.

Anemia in

Chronic Heart Failure.

Congest Heart Fail

2009;

15

: 87–92.

16. Man-Fai Sim V, Chi Yuen Nam M, Riley S,

et al

. Anemia in older

people with chronic heart failure: the potential cost.

Technol Health Care

2009;

17

: 377–385.

17. Kalra PR, Collier T, Cowie MR,

et al

. Heamoglobin concentration and

prognosis in new cases of heart failure.

Lancet

2003;

362

: 211–212.

18. Silverberg DS, Wexler D, Blum M,

et al

. The use of subcutaneous eryth-

ropoietin and intravenous iron for the treatment of the anemia of severe,

resistant congestive heart failure improves cardiac and renal function,

functional cardiac class, and markedly reduces hospitalizations.

J Am

Coll Cardiol

2000;

35

: 1737–1744.

19. Silverberg DS, Wexler D, Blum M, Iaina A. The cardio renal anemia

syndrome: correcting anemia in patients with resistant congestive heart

failure can improve both cardiac and renal function and reduces hospi-

talization.

Clin Nephrol

2003;

60

(Suppl 1): S93–S102.

20. World Health Organization/United Nations University/UNICEF. Iron

deficiency anemia, assessment, prevention and control: a guide for

programme managers, Geneva, WHO, 2001.

21. National Kidney Foundation K/DOQI clinical practice guidelines for

chronic kidney disease: evaluation, classification, and stratification.

Am

J kidney Dis

2002;

39

(Suppl): S1–S266.

22. McCullough PA, Barnard D, Clare R,

et al

. Anemia and associ-

ated clinical outcomes in patients with heart failure due to reduced left

ventricular systolic function.

Clin Cardiol

2013;

36

: 611–620.

23. Katz SD. Mechanisms and treatment of anemia in chronic heart failure.

Congest Heart Fail

2004;

10

: 243–247.

24. Ezekowitz JA, McAlister FA, Armstrong PW. Anemia is common in

heart failure and is associated with poor outcomes.

Circulation

2003;

107

: 223–225.

25. Witte KK, Desilva R, Chattopadhyay S,

et al

. Are hematinic deficien-

cies the cause of anemia in chronic heart failure?

Am Heart J

2004;

147

:

924–930.

26. Mukaya JE, Ddungu H, Ssali F,

et al

. Prevalence and morphological

types of anemia and hookworm infestation in the medical emergency

ward, Mulago Hospital, Uganda.

S Afr Med J

2009;

99

: 881–886.